SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 56.97 |
Enterprise Value ($M) | 36.99 |
Book Value ($M) | 19.00 |
Book Value / Share | 0.42 |
Price / Book | 3.00 |
NCAV ($M) | 18.70 |
NCAV / Share | 0.41 |
Price / NCAV | 3.05 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.92 |
Return on Assets (ROA) | -0.55 |
Return on Equity (ROE) | -1.01 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.64 |
Current Ratio | 2.64 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 45.05 |
Assets | 45.36 |
Liabilities | 26.35 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -36.32 |
Net Income | -37.61 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -35.03 |
Cash from Investing | -0.03 |
Cash from Financing | 20.19 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | BlackRock, Inc. | 4.96 | -3.18 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
103,288 | 394,366 | 26.19 | |
39,191 | 317,347 | 12.35 | |
20,917 | 57,595 | 36.32 | |
61,608 | 251,809 | 24.47 | |
(click for more detail) |
Similar Companies | |
---|---|
PALI – Palisade Bio, Inc. | PASG – Passage Bio, Inc. |
PCSA – Processa Pharmaceuticals, Inc. | PHIO – Phio Pharmaceuticals Corp. |
PLUR – Pluri Inc. |
Financial data and stock pages provided by
Fintel.io